Archives: News

Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to earth. Over the past several decades, drug-development costs have risen significantly, from $250 million per approved drug prior to the 1990s to $403 million …

Drug Prices Are Too Expensive: Here’s How Technology Can Fix That Forbes Technology Council Read More »

Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the answer to secure the supply chain? Counterfeit medicines are a multi-billion dollar problem on a global level. From the size, shape and colour of the pharmaceuticals, to the packaging made to look like the real …

Can blockchain solve pharma’s counterfeit drug problem? Pharmaphorum Read More »

When a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to differentiate their early stage assets, they approached Innoplexus. That decision could not have been more apt. Since its inception in 2011, the Indo-German company has been working to help transform the global healthcare market, especially focussing on …

How Innoplexus uses smart and on-edge technology to help its pharma clients find relevant answers hidden in unstructured data Read More »

Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his 2005 book chapter Bridging the Quality Chasm: “Between $.30 and $.40 of every dollar spent on healthcare is spent on the costs of poor quality. This extraordinary number represents slightly more than a half-trillion dollars …

Leveraging AI and Blockchain to Transform Healthcare Read More »

The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the regulated medicines on the pharmacy shelves. It has been one of the top industry performers of the past three decades. By maintaining the highest safety and quality standards, many pharma business units along the supply …

How Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum Read More »

In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world. As the Nobel-prize-winning economist Daniel Kahneman wrote in his book Thinking, Fast and Slow, “Intelligence is not only the ability to reason; it is also the ability to find relevant …

Why pharma companies need to upgrade their intelligence Pharmaphorum Read More »

When medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel therapeutics to market.     As Ginny Rometti, the current CEO of IBM and also the first woman to head the company is quoted as saying: “Some people call this artificial intelligence, but the reality …

How artificial intelligence powers healthcare innovation Digital Commerce 360 Read More »

The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What can be done to overcome this issue?  We live in an exciting time for the pharmaceutical industry. Cutting-edge technologies like artificial intelligence (AI) and Blockchain are making headlines or revolutionising everything from drug discovery to …

Solving the Big Data problem in pharma innovation Pharmaphorum Read More »